Drug intelligence / Profile preview

methylprednisolone + ASTED

Development stage
Unknown
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

This is a combination drug consisting of methylprednisolone and "ASTED." Methylprednisolone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties. It acts by binding to the glucocorticoid receptor, modulating gene expression, and suppressing the immune response. Methylprednisolone is used in a wide range of conditions including allergic reactions, autoimmune diseases, asthma exacerbations, arthritis, and other inflammatory or immune-mediated disorders[4][6][8]. The mechanism of action involves inhibition of leukocyte infiltration at the site of inflammation, interference with mediators of inflammatory response, suppression of humoral immune responses, and reduction in edema or scar tissue formation. The identity or pharmacological nature of "ASTED" could not be determined from available sources; it does not correspond to any recognized pharmaceutical ingredient or established abbreviation in drug databases as of June 2025. Therefore, no information about its mechanism(s), class(es), developer(s), manufacturer(s), or clinical use can be provided.

02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on methylprednisolone + ASTED.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylprednisolone + ASTED.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call